Apellis Pharmaceuticals Inc

NASDAQ:APLS   3:59:47 PM EDT
53.00
+8.74 (+19.75%)
Products

Apellis Announces Submission Of Pegcetacoplan Marketing Applications To FDA And EMA For Patients With PNH

Published: 09/15/2020 11:28 GMT
Apellis Pharmaceuticals Inc (APLS) - Apellis Announces Submission of Pegcetacoplan Marketing Applications to FDA and Ema for Patients With Pnh.
Apellis Pharmaceuticals - FDA and Ema Decisions on Acceptance of NDA and Maa Submissions Are Expected in Q4.